Feature | Radiology Imaging | October 30, 2019 | By Anna Dussing

Advancements in Bioprinting

New breakthroughs in 3-D printing could be a potential solution for organ failure in the future

Physicians at North Shore University Hospital/Feinstein Institute for Medicine in Manhassett, N.Y., use a 3-D printer to assist with medical cases.

Physicians at North Shore University Hospital/Feinstein Institute for Medicine in Manhassett, N.Y., use a 3-D printer to assist with medical cases.

This 3-D printed spine recreation from the Mayo Foundation for Medical Education and Research enables physicians to study varying degrees of curvature of the spine.

This 3-D printed spine recreation from the Mayo Foundation for Medical Education and Research enables physicians to study varying degrees of curvature of the spine.

A variety of 3-D printed models displayed by Stratasys at a recent RSNA conference.

A variety of 3-D printed models displayed by Stratasys at a recent RSNA conference.

Anna Dussing

Anna Dussing

The advancement of medical technology offers a plethora of options for healthcare professionals and patients alike. New technologies and clinical trials are solving the way we treat diseases and interface with patients. Recent breakthroughs in three-dimensional printing (3-D) may have hit upon a solution for organ failure.1

Previously, patients faced with malignant diseases that destroyed major organs were required to wait for transplants. However, the negative effects of organ transplants include long waits where the patient’s need is disproportionate to the available resources of these vital organs. Even if a transplant is successful, there is no guarantee the body will adapt to the unfamiliar organ.

Though transplants are still the predominant treatments for organ failure, new advancements in 3-D printing may solve issues that can occur with the traditional medical regimen.

What is 3-D Printing?

Three-dimensional printing technology in the medical sphere is divided into two general categories: inorganic printing, which uses polymers to model portions of the body or to create implants, and bioprinting, which uses cells to create organic material.

Three-dimensional bioprinting may one day replace ordinary organ transplants. This technology has the potential to solve issues of extended waits and poor autoimmune reactions in defense against the transplanted organ. Bioprinting uses specialized implants that will match the patient’s DNA, which could help solve anxiety and concerns that are experienced with traditional organ transplants.

There are three sources for printing implementation: patient computed tomography (CT), magnetic resonance imaging (MRI) and 3-D ultrasound imaging datasets. CTs are often better than X-rays and can give more detailed images of the body for further comprehension. Similarly, MRIs show better soft tissue imaging of organs. Ultrasounds are also relevant as they allow creation of images used for 3-D printing.

Three-dimensional printing has most frequently been employed for pediatric, small-scale or intricate planning where procedures are too elaborate to navigate without the advanced 3-D technology. By printing solid representations of a patient’s body, doctors are able to plan and practice surgeries using a patient-tailored model.

Beyond using 3-D printing to plan surgeries, scientists are now discovering ways to integrate 3-D printing technology into a patient’s body. This could be used either to print inorganic medical implants such as orthopedic implants or even organic organ replacements. This practice is known as bioprinting.

Where is 3-D Printing Technology Today?

Three-dimensional printing has steadily progressed past inorganic material. In 2017, Penn State University engineers discovered a revolutionary way to print tissues and organs.2 The practice involves an “electrospinning printer [which] is capable of spinning fibers seeded with cells to create fiber layers.” This technology is both cheaper and it “provides an opportunity to spin polymer fibers such as collagen layers whilst offering added precision and more control over the patterns created.” In addition to this finding, scientists at Rice’s Brown School of Engineering in the bioengineering department were able to construct a 3-D printed organ that mimics lungs.3

As organs are in high demand, there is an anticipation for whole working organs made with 3-D bioprinting technology to replace failing livers, heart or lungs. With the production of real human tissue, organ replicas and functional organ structures, bioprinting may present a resolution to the risks of traditional transplants.

These advancements pertain especially to patients with rare cancers. Those in later cancer stages often suffer organ failure, with little hope of replacement or treatment. Previously untreatable cancers may now have met their match. Mesothelioma cancer is typically diagnosed once it reaches a late stage, leaving patients with a life expectancy of 12-21 months. Three-dimensional printing of a replacement lung would be an ideal solution to curing this devastating cancer in patients diagnosed with an early onset of the disease, as most often it develops in the lining of the lungs.4

Along with mesothelioma and pediatric procedures, 3-D printing would also be groundbreaking for cases where the internal vasculature demands detail. In these instances, detail becomes critical for the organ to function properly when transplanted.

Bioprinting will be transformative to organ replacements that are central to the body and dependent on the vasculature. Even more, 3-D printing in modern medicine is not exclusive to cancer or surgery, but also dental equipment, medication dosage and pharmacology, and manufacturing of medical tools and devices. This opens up 3-D printing to a range of applications within the medical field to solve complicated problems.

The Current State of Research

Though bioprinting can successfully make human tissue, doctors and scientists are still figuring out the particularities of whether that tissue will operate congruously in the body when implanted. Just because the reproduced tissue mimics real tissue does not guarantee that it will
act seamlessly.

Scientists are determined to troubleshoot these issues. In April 2019, a team from Tel Aviv University bioprinted “the world’s first 3-D vascularized engineered heart using a patient’s own cells and biological materials.”5 Though the heart is only the size of a rabbit’s and not in a condition to be readily implanted, the research team considers this a victory. After making a complete heart with every blood vessel, chamber structure and cell placement intact, they are now focused on teaching a heart to behave like a living, beating organ.

Additionally, according to Science Daily, a study done in May 2019 concerning a 3-D printed lung posited that bioprinting is the leading research to organ transplants. The article states that 15 collaborators from Rice, University of Washington, Duke University, Rowan University and design firm Nervous System formulated an open-source bioprinting technology called the stereolithography apparatus for tissue engineering. This system was able to make “soft, water-based, biocompatible gels with intricate internal architecture in a matter of minutes.” In tests with the lung-like 3-D copy, this system confirmed that the tissues were able to withstand biological processes like blood flow and breathing.

Bioprinting has drastically improved the medical world. Scientists have figured out how to create human tissue and whole organ replicas. The 3-D printed lung is another win for engineers who were skeptical of whether an organ could resist breakdown or failure in response to the natural bodily processes for which it was intended. Now, they can move forward with this knowledge, and research attempts to effectively resolve the need for organ transplants with combined efforts of bioprinting and 3-D printing.

Anna Dussing is a health journalist for Mesothelioma.com. The organization’s work is focused on awareness and advocacy for mesothelioma cancer and aims for a complete ban of asbestos in the United States. Her focus is on raising awareness of toxin exposure and the potential illnesses and health impacts caused by it.

References:

1.    The Future of 3-D Printing in Medicine. www.dicardiology.com/article/future-3-d-printing-medicine. Accessed Sept. 30, 2019.

2.    Researchers Find New Low-cost Ways to 3D Print Living Tissues and Organs. https://all3dp.com/researchers-find-new-ways-3d-print-living-tissues-organs/. Accessed Sept. 30, 2019.

3.    Scientists Successfully 3D Print an Organ That Mimics Lungs. https://www.popularmechanics.com/science/health/a27355578/3d-print-lungs/. Accessed Sept. 30, 2019.

4.    https://www.mesothelioma.com/. Accessed Sept. 30, 2019.

5.    Tel Aviv University scientists print first 3D heart using patient’s biological materials. https://www.eurekalert.org/pub_releases/2019-04/afot-tau041519.php. Accessed Sept.
    30, 2019.

Related Content

A patient implanted with the Axonics System can undergo MRI examinations safely with radio frequency (RF) Transmit Body or Head Coil under the conditions outlined in the Axonics MRI Conditional Guidelines.

A patient implanted with the Axonics System can undergo MRI examinations safely with radio frequency (RF) Transmit Body or Head Coil under the conditions outlined in the Axonics MRI Conditional Guidelines.

News | Magnetic Resonance Imaging (MRI) | July 02, 2020
July 2, 2020 — Axonics Modulation Technologies, Inc., a medical technology company that has developed and is commerci
This data represents wave 2 of a QuickPoLL survey conducted in partnership with an imagePRO panel created by The MarkeTech Group (TMTG), regarding the effects of COVID-19 on their business

Getty Images

Feature | Coronavirus (COVID-19) | July 01, 2020 | By Melinda Taschetta-Millane
A 3-D ultrasound system provides an effective, noninvasive way to estimate blood flow that retains its accuracy across different equipment, operators and facilities, according to a study published in the journal Radiology.

Volume flow as a function of color flow gain (at a single testing site). For each row the color flow c-plane and the computed volume flow are shown as a function of color flow gain. The c-plane is shown for four representative gain levels, whereas the computed volume flow is shown for 12–17 steps across the available gain settings. Flow was computed with (solid circles on the graphs) and without (hollow circles on the graphs) partial volume correction. Partial volume correction accounts for pixels that are only partially inside the lumen. Therefore, high gain (ie, blooming) does not result in overestimation of flow. Systems 1 and 2 converge to true flow after the lumen is filled with color pixel. System 3 is nearly constant regarding gain and underestimates the flow by approximately 17%. Shown are mean flow estimated from 20 volumes, and the error bars show standard deviation. Image courtesy of the journal Radiology

News | Ultrasound Imaging | July 01, 2020
July 1, 2020 — A 3-D ultrasound
Researchers reviewed results of prostate biopsies on over 3,400 men who had targets identified on prostate MRI and found that the positive predictive value of the test for prostate cancer was highly variable at different sites
News | Prostate Cancer | July 01, 2020
July 1, 2020 — Prostate MRI is an emerging technology used to identify and guide treatment for...
R2* maps of healthy control participants and participants with Alzheimer disease. R2* maps are windowed between 10 and 50 sec21. Differences in iron concentration in basal ganglia are too small to allow visual separation between patients with Alzheimer disease and control participants, and iron levels strongly depend on anatomic structure and subject age. Image courtesy of Radiological Society of North America

R2* maps of healthy control participants and participants with Alzheimer disease. R2* maps are windowed between 10 and 50 sec21. Differences in iron concentration in basal ganglia are too small to allow visual separation between patients with Alzheimer disease and control participants, and iron levels strongly depend on anatomic structure and subject age. Image courtesy of Radiological Society of North America

News | Magnetic Resonance Imaging (MRI) | July 01, 2020
July 1, 2020 — Researchers using magnetic...
Imaging Artificial Intelligence (AI) provider Qure.ai announced its first US FDA 510(k) clearance for its head CT scan product qER. The US Food and Drug Administration's decision covers four critical abnormalities identified by Qure.ai's emergency room product.
News | Artificial Intelligence | June 30, 2020
June 30, 2020 — Imaging Artificial Intelligence (AI) provider Qure.ai announced its first US FDA 510(k) clearance for
In new QuickPoLL survey on imaging during the pandemic, responses were tallied from around 170 radiology administrators and business managers, who are part of an imagePRO panel created by The MarkeTech Group (TMTG), regarding the effects of COVID-19 on their business. TMTG is a research firm specializing in the medical device, healthcare and pharmaceutical industries.
Feature | Coronavirus (COVID-19) | June 30, 2020 | By Melinda Taschetta-Millane
Thoracic findings in a 15-year-old girl with Multisystem Inflammatory Syndrome in Children (MIS-C). (a) Chest radiograph on admission shows mild perihilar bronchial wall cuffing. (b) Chest radiograph on the third day of admission demonstrates extensive airspace opacification with a mid and lower zone predominance. (c, d) Contrast-enhanced axial CT chest of the thorax at day 3 shows areas of ground-glass opacification (GGO) and dense airspace consolidation with air bronchograms. (c) This conformed to a mosai

Thoracic findings in a 15-year-old girl with Multisystem Inflammatory Syndrome in Children (MIS-C). (a) Chest radiograph on admission shows mild perihilar bronchial wall cuffing. (b) Chest radiograph on the third day of admission demonstrates extensive airspace opacification with a mid and lower zone predominance. (c, d) Contrast-enhanced axial CT chest of the thorax at day 3 shows areas of ground-glass opacification (GGO) and dense airspace consolidation with air bronchograms. (c) This conformed to a mosaic pattern with a bronchocentric distribution to the GGO (white arrow, d) involving both central and peripheral lung parenchyma with pleural effusions (black small arrow, d). image courtesy of Radiological Society of North America

News | Coronavirus (COVID-19) | June 26, 2020
June 26, 2020 — In recent weeks, a multisystem hyperinflammatory condition has emerged in children in association wit